PHARM.ASPHARM.ASAMS
Loading
Debt Growth Under PressureDecelerating
Percentile Rank62
5Y CAGR-9.2%
Year-over-Year Change
Year-over-year debt growth rate
5Y CAGR
-9.2%/yr
Long-term compound
Percentile
P62
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 2.02% |
| Q2 2025 | 7.71% |
| Q1 2025 | 6.08% |
| Q4 2024 | -11.62% |
| Q3 2024 | 4.15% |
| Q2 2024 | -27.02% |
| Q1 2024 | -2.53% |
| Q4 2023 | 4.61% |
| Q3 2023 | -3.61% |
| Q2 2023 | -0.16% |
| Q1 2023 | 2.22% |
| Q4 2022 | 19.77% |
| Q3 2022 | -6.59% |
| Q2 2022 | -5.57% |
| Q1 2022 | 10.56% |
| Q4 2021 | 0.00% |
| Q2 2021 | 10.97% |
| Q1 2021 | -5.31% |
| Q4 2020 | 6.25% |
| Q3 2020 | 5.31% |
| Q2 2020 | 3.29% |
| Q1 2020 | 141.44% |
| Q4 2019 | -12.24% |
| Q3 2019 | -11.21% |
| Q2 2019 | -7.04% |
| Q1 2019 | -3.80% |
| Q4 2018 | -7.73% |
| Q3 2018 | -6.40% |
| Q2 2018 | -0.31% |
| Q1 2018 | -0.65% |
| Q4 2017 | -6.08% |
| Q3 2017 | 0.32% |
| Q2 2017 | 47.69% |
| Q1 2017 | -1.11% |
| Q4 2016 | 313.79% |
| Q3 2016 | -3.22% |
| Q2 2016 | 1.33% |
| Q1 2016 | 0.70% |
| Q4 2015 | -5.61% |
| Q3 2015 | 1381.41% |